Bad News for Retirees

Stocks staged a death-defying recovery in Q1.

In fact, they did something they haven’t done in more than 80 years: after dropping more than 10% at the start of the year, they finished the quarter in the black.

Unfortunately for you, there’s a downside to this news:

After their Q1…

Read More

Tags: Title iii Warren buffett

The Most Profitable Fund of All Time?

For decades now, investors have poured money into all types of funds:

Mutual Funds...

Index Funds...

ETFs…

All with the goal of capturing financial upside and lowering risk.

Unfortunately, most of these funds stink. In fact, a 2014 study performed by Dow Jones concluded that 98% of mutual funds failed…

Read More

Tags: Venture capital Venture capital-fund

Could This Robot Stop a Terrorist Attack?

I live in one of the most highly trafficked neighborhoods of New York City.

My home is one block from Penn Station, one of the busiest transit hubs in the country...

The Macy’s flagship store is directly across the street from me—that’s where they host the Thanksgiving Day parade…

Read More

Tags: Defense Knightscope Security

Up 45% in U.K. -- The U.S. Is Next

I’m proud to be an American...

But lately, I’ve become jealous of UK citizens.

I mean, first they came up with James Bond and Fish & Chips (I’m a big fan of both)...

Then, according to the World Health Organization, they started living longer than us.

But now they’re kicking…

Read More

Tags: International crowdfunding Title iii

Turn Your Phone Into a 3D Printer

You rely on Crowdability to bring you the best deals. Now, rely on us to share the most up-to-date news, trends and opinion. You won’t find this stuff in the mainstream press. Look for it every Friday morning.

Russian Billionaire Transferring Brain Into a…

Read More

Tags: 3d printing Diabetes Dna

We hired this man to help you get rich...

As you might know by now, we’ve recently partnered with one of the top investment experts in the world: James Altucher.

For the past few weeks, James has been sharing his ideas in the Crowdability newsletter...

And just two days ago, he pulled back the curtain on a special project…

Read More

Tags: James altucher

A Cure for Alzheimer's?

At 5:45 on a recent afternoon, I received an email from a friend:

Matt,
Here’s a deck for a company one of our biotech advisors is raising money for. Basically they looked at why all the big pharma trials failed, and they have a solution for what went wrong.…

Read More

Tags: Biotech Disruptive tech-research